AstraZeneca's self-inflicted wounds
The Oxford-AstraZeneca is hailed as a cheap and easy jab to fight COVID-19. But a series of corporate stumbles have clouded it's promise, and science backed results.
The podcast Front Burner is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.